1. Home
  2. BOLD vs HUIZ Comparison

BOLD vs HUIZ Comparison

Compare BOLD & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • HUIZ
  • Stock Information
  • Founded
  • BOLD 2018
  • HUIZ 2006
  • Country
  • BOLD United States
  • HUIZ China
  • Employees
  • BOLD N/A
  • HUIZ N/A
  • Industry
  • BOLD
  • HUIZ Specialty Insurers
  • Sector
  • BOLD
  • HUIZ Finance
  • Exchange
  • BOLD Nasdaq
  • HUIZ Nasdaq
  • Market Cap
  • BOLD 33.4M
  • HUIZ 35.2M
  • IPO Year
  • BOLD 2024
  • HUIZ 2020
  • Fundamental
  • Price
  • BOLD $1.25
  • HUIZ $3.48
  • Analyst Decision
  • BOLD Buy
  • HUIZ Hold
  • Analyst Count
  • BOLD 4
  • HUIZ 1
  • Target Price
  • BOLD $4.00
  • HUIZ $2.30
  • AVG Volume (30 Days)
  • BOLD 143.3K
  • HUIZ 15.0K
  • Earning Date
  • BOLD 11-05-2025
  • HUIZ 12-09-2025
  • Dividend Yield
  • BOLD N/A
  • HUIZ N/A
  • EPS Growth
  • BOLD N/A
  • HUIZ N/A
  • EPS
  • BOLD N/A
  • HUIZ 0.25
  • Revenue
  • BOLD N/A
  • HUIZ $186,519,166.00
  • Revenue This Year
  • BOLD N/A
  • HUIZ $22.67
  • Revenue Next Year
  • BOLD N/A
  • HUIZ $8.55
  • P/E Ratio
  • BOLD N/A
  • HUIZ $14.34
  • Revenue Growth
  • BOLD N/A
  • HUIZ 19.12
  • 52 Week Low
  • BOLD $1.00
  • HUIZ $1.50
  • 52 Week High
  • BOLD $3.75
  • HUIZ $10.58
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 40.98
  • HUIZ 48.49
  • Support Level
  • BOLD $1.37
  • HUIZ $3.45
  • Resistance Level
  • BOLD $1.52
  • HUIZ $3.80
  • Average True Range (ATR)
  • BOLD 0.07
  • HUIZ 0.19
  • MACD
  • BOLD -0.03
  • HUIZ -0.04
  • Stochastic Oscillator
  • BOLD 6.25
  • HUIZ 27.14

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: